MSTN and proximal spinal muscular atrophy: Previous work has shown that myostatin inhibition is ineffective at preventing atrophy in the face of complete muscle paralysis, while we have shown that muSRK-015P effectively preserves muscle mass when capacity for minimal physical activity is retained, as is seen in SMA patients (84,85).